Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR1 | O43613 | 2/20 | 0.63 |
| ▸ | HCRTR2 | O43614 | 2/20 | 0.63 |
| ▸ | TP53 | P04637 | 6/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | MME | P08473 | 1/20 | 0.43 |
| ▸ | TAS1R3 | Q7RTX0 | 3/20 | 0.41 |
| ▸ | TAS1R1 | Q7RTX1 | 3/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2010621 | 0.94 | HCRTR1 (0.63) | HCRTR1HCRTR2TP53NPC1RAB9A | |
| SCHEMBL2014534 | 0.86 | HCRTR1 (0.66) | HCRTR1HCRTR2TP53NPC1RAB9A | |
| SCHEMBL2013109 | 0.85 | HCRTR1 (0.64) | HCRTR1HCRTR2TP53NPC1RAB9A | |
| SCHEMBL2015002 | 0.85 | HCRTR1 (0.69) | HCRTR1HCRTR2TP53NPC1RAB9A | |
| SCHEMBL2010631 | 0.85 | HCRTR1 (0.65) | HCRTR1HCRTR2TP53NPC1RAB9A | |
| SCHEMBL2013242 | 0.84 | HCRTR1 (0.70) | HCRTR1HCRTR2NPC1RAB9A | |
| SCHEMBL2015950 | 0.84 | HCRTR1 (0.70) | HCRTR1HCRTR2NPC1RAB9A | |
| SCHEMBL2012339 | 0.84 | HCRTR1 (0.63) | HCRTR1HCRTR2TP53NPC1RAB9A | |
| SCHEMBL2011910 | 0.84 | HCRTR1 (0.69) | HCRTR1HCRTR2NPC1RAB9A | |
| SCHEMBL2013785 | 0.84 | HCRTR1 (0.67) | HCRTR1HCRTR2NPC1RAB9ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011073316-A1 | 4-ARYL-BUTANE-1,3-DIAMIDES | NOVARTIS AG (CH) | 2011-06-23 | — | — | WO | claimed |
| WO-2011073316-A1 | 4-ARYL-BUTANE-1,3-DIAMIDES | NOVARTIS AG (CH) | 2011-06-23 | — | — | WO | disclosed |